Company Overview
Apexcela Co., Ltd. (www.apexcela.com) established in 2010, is a life sciences company. It was funded 100% by CPB Equity Co., Ltd. (operating company of Crown Property Bureau) that is committed to providing affordable high quality medicines to all and promoting commercialization of biopharmaceuticals for healthcare through licensing and in-house manufacturing of products by Siam Bioscience Co., Ltd. (www.siambioscience.com). Apexcela’s products will address unmet healthcare issues in the therapeutic areas such as oncology, hematology, nephrology, autoimmune disorders, cardiovascular, and metabolic disorders.